Jan 27, 2021 7:30 am EST Heat Biologics Announces Publication of Additional Preclinical COVID-19 Vaccine Results
Jan 20, 2021 7:30 am EST Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021
Jan 08, 2021 4:00 pm EST Heat Biologics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
Dec 16, 2020 7:30 am EST Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19
Oct 07, 2020 7:30 am EDT Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator
Sep 09, 2020 7:30 am EDT Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th